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Abstract: This study evaluated the antioxidant activity of five resveratrol analogs by relating the activity of the molecule 
with its chemical structure. The five resveratrol analogs were synthesized and the antioxidant activity was evaluated using 
the DPPH method. The resveratrol was used as the reference standard. A descriptive statistical analysis and ANOVA 
followed by the Tukey test, with the aid of software. The antioxidant activity of resveratrol analogs was considered 
statistically different, with the analog A which showed activity superior to the others. The five analogs presented lower 
antioxidant activity than the reference standard (p <0.001). According to the findings, hydroxylation was the molecular 
modification that gave the best evaluated antioxidant activity result. Resveratrol analogs may have an important anti-
oxidative activity, but with the one with the higher IC50 was presented by the natural compound. 
Keywords: Antioxidants, Chemical Synthesis, 2,2-diphenyl-1-picrylhydrazyl, Hydroxylation, Resveratrol, Structure-Activity 
Relationship. 
INTRODUCTION  
The search for a healthy life has stimulated habit changes 
in the world population, as the growing interest in the use of 
natural products [1]. Flavonoids are worth mentioning 
because they cover a wide range of substances capable of 
meeting this need [2], one of them being resveratrol (3,5,4’-
trihydroxyestilbene) [3]. 
Regarded as a chemo preventive agent, polyphenolic 
phytoalexin this belongs to the class of stilbenes, actively 
protecting cells against oxidative damage observed in several 
diseases caused by reactive oxygen species (ROS) [4] and 
reactive nitrogen species (RNS) [5]. 
Resveratrol is particularly present in the grape and its 
derivatives which has become a composite of interest for its 
broad spectrum of action as an antioxidant, cancer [6] and 
aging preventive [7], cardioprotective [3], anti-inflammatory 
[4] and its ability to reduce obesity [8]. Studies suggest an 
important participation of this substance as a protector of 
acute kidney disease [4] and Alzheimer's disease [9]. As an 
anti-proliferative agent in certain types of tumors, resveratrol 
works by inducing apoptosis [10]. The combination of this 
drug with certain drugs [11], ionizing radiation, or cytokines 
may be a way to optimize anticancer therapy [12]. 
Another related benefit of resveratrol is the reduction of 
hepatotoxic effects caused by isoniazid and rifampicin, drugs 
used to treat tuberculosis [13]. Its antioxidant activity also 
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gives it the ability to selectively inhibit the monoamine 
oxidase enzyme type A (MAO-A) [14], the target of drugs 
used as antidepressants [15]. 
However, according to some studies, stilbenes, despite 
being well absorbed, have low bioavailability [12], which is 
one of the limiting factors for its wide use as medicine. This 
emphasizes the importance of searching for molecules 
similar to resveratrol that retain antioxidant activity, but with 
improved bioavailability. 
This study evaluated the antioxidant activity of five 
resveratrol analogs by relating the activity of the molecule 
with its chemical structure. 
MATERIAL AND METHODS 
Chemistry 
A series of azaresveratrol derivatives were synthesized 
and their antioxidant activities were examined. The structure 
of this compounds, 1-N-(4’-hydroxy-benzylidene) aniline 
(A), 1-N-(4’-carboxy-benzylidene) aniline (B), 1-N-(4’-
nitro-benzylidene) aniline (C), 1-N-(4’-methoxy-benzyli-
dene) aniline (D), 1-N-(4’-dimethylamino-benzylidene) 
aniline (E) are show in the Table 1. 
All compounds were characterized by 
1
H and 
13
C NMR, 
and melting point (Table 2) and were in accord with data in 
the literature [16-19]. 
Antioxidant Activity 
The antioxidant activity was evaluated using the 2,2-
diphenyl-1-picrylhydrazyl (DPPH; Sigma-Aldrich, USA) 
assay, described by Sreejayan and Rao [20], with minor 
modifications. This method is based on the DPPH reduction 
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Table 1. Concentration of Synthetic Resveratrol Analogs and of the Standards that Inhibits 50% of DPPH Radicals 
 
Sample Chemical Structure IC50 (g/mL)* 
A N
OH
 
103.8 
B N
COOH
 
279.7 
C N
NO2
 
356.6 
D N
OCH3
 
528.0 
E N
N(CH3)2
 
609.7 
Resveratrol 
OH
OH
HO
 
8.5 
* p < 0.05 for comparison between average values of IC50 of resveratrol and resveratrol analogs. 
 
Table 2. Spectral Data of Aza-Stilbene Derivatives 
 
Compounds   Himine   C=Nimine Melting point 
A 8.44 160.0 89.2-90.7 
B 8.72 159.8 220.4-221.6 
C 8.80 158.8 89.6-90.7 
D 8.51 159.8 61.4-62.1 
E 8.39 159.9 96.8-97.3 
The NMR experiments were performed at 300 MHz for 
1
H and 75 MHz for 
13
C in DMSO-d6 (ppm) and melting point (ºC). 
in the presence of an antioxidant (AH) a proton donor (H
+
) 
for a non-radical (DPPH-H) [21]. 
A 150 L of a DPPH ethanolic solution of 0.05 mM were 
added to 50 L of ethanol solution of resveratrol analogs at 
concentrations from 0.97 to 250 g /mL in 96-well plates. 
Resveratrol (trans-resveratrol 99.0%, Attivos Magistrais, 
Brazil) was used as a standard at the same concentrations. 
Reactions elapsed at room temperature for 30 minutes in 
the dark and then the absorbance was read in a 
spectrophotometer (= 510 nm).  
Inhibition of DPPH radical was calculated using the 
equation: 
% of inhibition = 100 x (A0 – As) / Ao 
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Being: Ao absorbance as the negative control and As a 
absorbance of test samples. 
The IC50 value was calculated from the line in the 
equation of the linear dispersion graph. All tests were 
performed in triplicate. 
Statistical Analysis 
We performed a descriptive statistical analysis and 
ANOVA followed by the Tukey test, with the aid of 
Statistical Package for Social Sciences (SPSS) v.14.0 for 
Windows software, to compare the average values of IC50 
calculated between the resveratrol analogs versus the 
standard. The level of significance was 5%. 
CONCLUSION 
The IC50 results revealed that substance A was the analog 
which needed the lowest concentration to inhibit the DPPH 
radical, but higher than the concentration shown by the 
reference standards and the other analogs showed no 
significant values (Table 1). 
The antioxidant activity of resveratrol analogs was 
considered statistically different, with the analog A showed 
activity superior to the others. 
The antioxidant activity of resveratrol analogs versus 
reference standard showed that these are statistically 
different bearing, the analogs, presented lower antioxidant 
activity than the resveratrol (p <0.001). 
Polyphenolic compounds such as resveratrol and 
flavonoids, have reducing properties and chemical structures 
that play an important role in neutralizing free radicals and 
chelation of transition metals, both in the initiation step as in 
the propagation of oxidative stress [22]. The intermediaries 
formed by the action of phenolic antioxidants are relatively 
stable due to the resonance of the aromatic ring in the 
structure of these substances [23]. 
Barreiros and colleagues describe five factors besides the 
chemical structure, which may influence flavonoid 
antioxidant activities. They are a reactive agent as a proton 
and electron donor agent, the stability of the flavonoil radical 
formed, reactivity with other antioxidants, the ability to 
chelate transition metals and solubility and interaction with 
membranes [24]. 
For Baur and Sinclair, in the case of resveratrol in 
mammals, it should be remembered that the compound has 
extremely low bioavailability and undergoes rapid clearance 
from the bloodstream [6]. Studies have shown that 
resveratrol is rapidly absorbed but quickly metabolized, 
usually in the first hour following oral administration in 
humans [25]. Some alternatives to improve resveratrol 
bioavailability were blocking its metabolism, the discovery 
of more potent compounds that mimic its effects or 
developing analogs with improved bioavailability [6]. 
Resveratrol has been shown to be extensively 
metabolized through glucuronidation and sulfation [25-27]. 
Where as glucuronidation was considered the main 
conjugation pathway [25]. Glucuronides and sulfates may 
bind one or two hydroxyl residues [28]. The sites of 
glucuronidation in the resveratrol molecule there are the 3 
and 4’ positions and major site of sulfate conjugation is the 
4’ position [29]. Resveratrol metabolites have a very short 
half-life and are subjected to rapid urinary elimination [25]. 
Based on this information the hydroxyl groups in 3 and 5 
positions were replaced by hydrogen atoms in order to 
minimize the formation of metabolic conjugates. In addition, 
evaluated functional groups were inserted in position 4'. 
According to Walle and colleagues, methylation of the 
polyphenols effectively blocks the metabolic conjugation 
reactions, thereby dramatically increasing both metabolic 
and stability [30]. This substitution was present in the analog 
D. 
Based on the concept of bioisosterism [31] the basic 
skeleton of trans-stilbene was modified by replacement of 
the central C=C linkage with a C=N double bond.  
In an attempt to preserve the resveratrol antioxidant 
activity, the five analog molecules in this compound kept the 
two aromatic rings and double bonds; they can form 
relatively stable intermediates due to resonance of the ring 
[32]. 
However, the compounds tested, only analog A, which 
has a hydroxyl as differential grouping in their structure, it 
presented satisfactory results as an antioxidant. This can be 
attributed to the reducing power of the aromatic hydroxyl 
that reduces reactive free radicals and produces the phenoxyl 
radical, stabilized by resonance [5]. The behavior of analog 
A also supports studies showing that the degree of 
antioxidant activities of is directly related to the number of 
hydroxyl groups present in the molecule [33, 34]. 
Regarding the structure of the analog B, uptake of free 
radical DPPH was due to the presence of the group carboxyl 
in C-4, but this occurred in a less effective manner than of 
the analog A, allowing to infer that the phenolic hydroxyl 
has greater potential to reduce. But for Rosa and colleagues 
the carboxyl groups in some locations can interact with 
metal ions, responsible for initiating the Fenton reaction, 
responsible for production of hydroxyl radical. Thus, 
molecules containing carbonyl group would be useful as 
metal chelators [35]. 
The analog C is a nitro compound and presented 
intermediary antioxidant activity. Most of the nitro 
compounds showed a bio enzymatic reduction mechanism 
and these results in the formation of free radicals, but with 
preferential toxicity to bacteria and parasites [36]. 
The analogs D and E had no significant results on the 
antioxidant activity test, which can be explained by the fact 
of not presenting the above mentioned analog groups and 
possibly by the lower polarity presented by methoxyl groups 
and amine, respectively. According to Chun and colleagues, 
the hydrophilic and hydrophobic behavior of phenolic 
compounds influence the antioxidant activity given by the 
DPPH assay, which primarily measures the antioxidant 
activity of soluble phenols in water [22]. 
It was found that the inclusion of carboxyl, nitro, 
methoxy and amine groups were not modifications of 
interest for the antioxidant activity improvement. 
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Although there were none, in this study of sufficiently 
large structural diversity, it is possible to observe that 
molecules with polar groups such as hydroxyl and carboxyl, 
confer a higher antioxidant activity than analogs with fewer 
polar groups such as methoxy and amine, highlighting the 
importance of a polar cluster in this position. 
According to the findings, hydroxylation was the 
molecular modification that gave the best evaluated 
antioxidant activity result by the DPPH method. However, 
this is lower than the reference standards tested. 
Resveratrol analogs may have an important antioxidant 
activity, but with the one with higher IC50 presented by the 
natural compound. 
Studies arising from the relationship between the 
properties of the analogs chemical structure and coupled 
with new molecular changes may contribute to the 
development of more effective bioactive molecules. 
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